Last Update15 Aug 25
As 3D Systems’ net profit margin and revenue growth forecasts remain unchanged at 0.72% and -4.5% respectively, the analyst consensus price target is also maintained at $3.25.
What's in the News
- 3D Systems launched the NextDent Jetted Denture Solution and NextDent 300 MultiJet printer in the U.S., enabling rapid, post-cure-free, single-piece, dual-material dentures with improved aesthetics and durability.
- The company’s bioprinting technology enabled FDA approval (De Novo) for a fully bioabsorbable, sutureless peripheral nerve repair device (COAPTIUM CONNECT with TISSIUM Light), developed with TISSIUM.
- A class action lawsuit alleges 3D Systems made false and misleading statements regarding customer demand, milestone-driven revenue recognition, and the impact on its Regenerative Medicine Program.
- 3D Systems reported weak Q4 2024 and Q1 2025 financials, withdrew its FY25 outlook due to macro headwinds and dental segment challenges, leading to sharp share price declines.
- The company completed a $92M convertible note private placement with a 5.875% interest rate and an initial conversion premium of 20%.
Valuation Changes
Summary of Valuation Changes for 3D Systems
- The Consensus Analyst Price Target remained effectively unchanged, at $3.25.
- The Net Profit Margin for 3D Systems remained effectively unchanged, at 0.72%.
- The Consensus Revenue Growth forecasts for 3D Systems remained effectively unchanged, at -4.5% per annum.
Key Takeaways
- Growth in healthcare and dental solutions, plus expanded digital manufacturing, positions the company for higher-margin recurring revenues and global market leadership.
- Strategic cost cuts, R&D commercialization, and industry shifts to decentralized production are set to drive sustainable profitability and diversify revenue streams.
- Prolonged macro uncertainty, delayed customer spending, aggressive restructuring, and rising competition threaten both 3D Systems' growth potential and long-term earnings stability.
Catalysts
About 3D Systems- Provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania.
- Demand for 3D Systems' healthcare solutions, particularly MedTech (personalized implants, trauma, and bone cancer treatments) and Dental (NextDent dentures), is benefitting from growing healthcare customization needs and rapid expansion of digital dentistry. These areas are poised to drive recurring, higher-margin service and product revenues as regulatory approvals expand globally, supporting both top-line and margin growth.
- The company's end-to-end additive manufacturing model (process, parts, printers) positions it to benefit from the shift toward on-demand, decentralized production and supply chain resiliency in sectors like aerospace, defense, and industrials. As adoption of additive manufacturing for production parts (beyond prototyping) accelerates, this model is likely to increase revenues and deliver operating leverage over time.
- Aggressive cost reduction initiatives-including in-sourcing manufacturing, global footprint consolidation, and automation of back-office functions-are expected to reduce COGS and OpEx, significantly improving gross margins and positioning the company for sustainable profitability and positive cash flow by 2026.
- Strategic R&D prioritization is moving from heavy investment (20% of sales) to commercialization of a refreshed portfolio of metal, polymer, and regenerative technologies, which is expected to result in increased product launches, expand addressable markets, and yield a better return on R&D, supporting long-term revenue and profit growth.
- Secular trends towards sustainability, efficient resource use, and supply chain localization are increasing demand for 3D printing and additive manufacturing, directly aligning with 3D Systems' distributed manufacturing and energy-efficient platform strengths, which should support resilient, diversified revenue streams and medium-term margin expansion.
3D Systems Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming 3D Systems's revenue will decrease by 4.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from -35.0% today to 0.7% in 3 years time.
- Analysts expect earnings to reach $2.6 million (and earnings per share of $-0.15) by about August 2028, up from $-144.8 million today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 185.9x on those 2028 earnings, up from -1.9x today. This future PE is greater than the current PE for the US Machinery industry at 24.5x.
- Analysts expect the number of shares outstanding to decline by 3.98% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.62%, as per the Simply Wall St company report.
3D Systems Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- 3D Systems is experiencing a significant and protracted decline in customer capital expenditures for new production capacity, primarily due to macroeconomic uncertainty and volatile global tariff environments, which have caused a 16% year-over-year revenue decline; this trend, if sustained, could result in continued revenue stagnation or contraction.
- The ongoing macro challenges and customer uncertainty around where to locate manufacturing assets have led to elongated sales cycles and delayed large-capex purchases, potentially muting 3D Systems' ability to convert its pipeline and recover top-line industrial growth in a timely manner, risking both near
- and long-term revenue targets.
- The company is undertaking aggressive restructuring, including headcount reduction, facility consolidation, and R&D spending cuts; while aimed at improving margins and cash flow, this could compromise 3D Systems' innovation engine and leave it less competitive versus rivals that maintain or increase R&D, negatively impacting long-term earnings potential.
- Competitive risk remains high, especially as 3D printing hardware for certain markets (like dental) becomes commoditized and new entrants or incumbents, perhaps with deeper resources or more innovation velocity, may erode 3D Systems' market share and pricing power, which would place pressure on both margins and future revenue growth.
- The company's business mix has increased dependency on service and healthcare revenues, but weak performance in key verticals such as Dental-hit by both end-customer weakness and large customer order volatility-exposes the firm to further earnings volatility should sector adoption rates or market growth disappoint, risking both net margins and predictable earnings streams.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $3.25 for 3D Systems based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $4.0, and the most bearish reporting a price target of just $2.5.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $359.5 million, earnings will come to $2.6 million, and it would be trading on a PE ratio of 185.9x, assuming you use a discount rate of 9.6%.
- Given the current share price of $2.09, the analyst price target of $3.25 is 35.7% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.